nodes	percent_of_prediction	percent_of_DWPC	metapath
Benzonatate—SCN5A—Cardiac Progenitor Differentiation—THY1—hematologic cancer	0.00534	0.071	CbGpPWpGaD
Benzonatate—SCN5A—Cardiac Progenitor Differentiation—ANPEP—hematologic cancer	0.00496	0.066	CbGpPWpGaD
Benzonatate—SCN5A—SIDS Susceptibility Pathways—TLX3—hematologic cancer	0.00325	0.0432	CbGpPWpGaD
Benzonatate—SCN5A—L1CAM interactions—CHL1—hematologic cancer	0.00275	0.0366	CbGpPWpGaD
Benzonatate—SCN5A—SIDS Susceptibility Pathways—PBX1—hematologic cancer	0.00225	0.0299	CbGpPWpGaD
Benzonatate—SCN5A—Cardiac Progenitor Differentiation—DKK1—hematologic cancer	0.00211	0.028	CbGpPWpGaD
Benzonatate—SCN5A—L1CAM interactions—CNTN2—hematologic cancer	0.00199	0.0264	CbGpPWpGaD
Benzonatate—SCN5A—Cardiac Progenitor Differentiation—NCAM1—hematologic cancer	0.00198	0.0263	CbGpPWpGaD
Benzonatate—SCN5A—SIDS Susceptibility Pathways—TCF3—hematologic cancer	0.00178	0.0237	CbGpPWpGaD
Benzonatate—SCN5A—SIDS Susceptibility Pathways—GATA2—hematologic cancer	0.00164	0.0218	CbGpPWpGaD
Benzonatate—SCN5A—Cardiac Progenitor Differentiation—CXCR4—hematologic cancer	0.00158	0.021	CbGpPWpGaD
Benzonatate—Convulsion—Alitretinoin—hematologic cancer	0.0015	0.00162	CcSEcCtD
Benzonatate—Confusional state—Thalidomide—hematologic cancer	0.0015	0.00162	CcSEcCtD
Benzonatate—Pruritus—Chlorambucil—hematologic cancer	0.00149	0.00161	CcSEcCtD
Benzonatate—Hypersensitivity—Cladribine—hematologic cancer	0.00148	0.00161	CcSEcCtD
Benzonatate—Convulsion—Ifosfamide—hematologic cancer	0.00148	0.0016	CcSEcCtD
Benzonatate—Rash—Busulfan—hematologic cancer	0.00148	0.0016	CcSEcCtD
Benzonatate—Dizziness—Bexarotene—hematologic cancer	0.00148	0.0016	CcSEcCtD
Benzonatate—Dizziness—Dasatinib—hematologic cancer	0.00148	0.0016	CcSEcCtD
Benzonatate—Feeling abnormal—Lenalidomide—hematologic cancer	0.00147	0.00159	CcSEcCtD
Benzonatate—Headache—Busulfan—hematologic cancer	0.00147	0.00159	CcSEcCtD
Benzonatate—Shock—Thalidomide—hematologic cancer	0.00146	0.00158	CcSEcCtD
Benzonatate—Pruritus—Nilotinib—hematologic cancer	0.00146	0.00158	CcSEcCtD
Benzonatate—Feeling abnormal—Hydroxyurea—hematologic cancer	0.00145	0.00157	CcSEcCtD
Benzonatate—Pruritus—Imatinib—hematologic cancer	0.00145	0.00157	CcSEcCtD
Benzonatate—SCN5A—SIDS Susceptibility Pathways—RET—hematologic cancer	0.00145	0.0193	CbGpPWpGaD
Benzonatate—Convulsion—Vincristine—hematologic cancer	0.00144	0.00156	CcSEcCtD
Benzonatate—Confusional state—Carmustine—hematologic cancer	0.00144	0.00155	CcSEcCtD
Benzonatate—Rash—Procarbazine—hematologic cancer	0.00144	0.00155	CcSEcCtD
Benzonatate—Headache—Procarbazine—hematologic cancer	0.00143	0.00154	CcSEcCtD
Benzonatate—Pruritus—Cladribine—hematologic cancer	0.00143	0.00154	CcSEcCtD
Benzonatate—Hypersensitivity—Vinblastine—hematologic cancer	0.00142	0.00154	CcSEcCtD
Benzonatate—Confusional state—Alitretinoin—hematologic cancer	0.00142	0.00154	CcSEcCtD
Benzonatate—Rash—Dasatinib—hematologic cancer	0.00141	0.00152	CcSEcCtD
Benzonatate—Rash—Bexarotene—hematologic cancer	0.00141	0.00152	CcSEcCtD
Benzonatate—Constipation—Bortezomib—hematologic cancer	0.00141	0.00152	CcSEcCtD
Benzonatate—Confusional state—Ifosfamide—hematologic cancer	0.00141	0.00152	CcSEcCtD
Benzonatate—Convulsion—Mitoxantrone—hematologic cancer	0.00141	0.00152	CcSEcCtD
Benzonatate—Rash—Fludarabine—hematologic cancer	0.0014	0.00152	CcSEcCtD
Benzonatate—Headache—Bexarotene—hematologic cancer	0.0014	0.00151	CcSEcCtD
Benzonatate—Headache—Dasatinib—hematologic cancer	0.0014	0.00151	CcSEcCtD
Benzonatate—Headache—Fludarabine—hematologic cancer	0.00139	0.00151	CcSEcCtD
Benzonatate—Nausea—Busulfan—hematologic cancer	0.00139	0.00151	CcSEcCtD
Benzonatate—Shock—Alitretinoin—hematologic cancer	0.00139	0.0015	CcSEcCtD
Benzonatate—Tremor—Cisplatin—hematologic cancer	0.00138	0.00149	CcSEcCtD
Benzonatate—Constipation—Vinorelbine—hematologic cancer	0.00137	0.00148	CcSEcCtD
Benzonatate—SCN5A—Axon guidance—ABL2—hematologic cancer	0.00137	0.0182	CbGpPWpGaD
Benzonatate—Dizziness—Nilotinib—hematologic cancer	0.00136	0.00147	CcSEcCtD
Benzonatate—Dizziness—Imatinib—hematologic cancer	0.00136	0.00147	CcSEcCtD
Benzonatate—Feeling abnormal—Bortezomib—hematologic cancer	0.00136	0.00147	CcSEcCtD
Benzonatate—Hypersensitivity—Melphalan—hematologic cancer	0.00135	0.00146	CcSEcCtD
Benzonatate—Nausea—Procarbazine—hematologic cancer	0.00135	0.00146	CcSEcCtD
Benzonatate—Feeling abnormal—Bleomycin—hematologic cancer	0.00134	0.00145	CcSEcCtD
Benzonatate—Confusional state—Irinotecan—hematologic cancer	0.00134	0.00144	CcSEcCtD
Benzonatate—Confusional state—Mitoxantrone—hematologic cancer	0.00134	0.00144	CcSEcCtD
Benzonatate—Dizziness—Cladribine—hematologic cancer	0.00133	0.00144	CcSEcCtD
Benzonatate—Nausea—Bexarotene—hematologic cancer	0.00133	0.00143	CcSEcCtD
Benzonatate—Nausea—Dasatinib—hematologic cancer	0.00133	0.00143	CcSEcCtD
Benzonatate—Feeling abnormal—Vinorelbine—hematologic cancer	0.00132	0.00143	CcSEcCtD
Benzonatate—Nausea—Fludarabine—hematologic cancer	0.00132	0.00143	CcSEcCtD
Benzonatate—Hypersensitivity—Lenalidomide—hematologic cancer	0.00132	0.00142	CcSEcCtD
Benzonatate—Constipation—Thiotepa—hematologic cancer	0.00131	0.00142	CcSEcCtD
Benzonatate—Shock—Irinotecan—hematologic cancer	0.0013	0.00141	CcSEcCtD
Benzonatate—Shock—Mitoxantrone—hematologic cancer	0.0013	0.00141	CcSEcCtD
Benzonatate—Pruritus—Melphalan—hematologic cancer	0.0013	0.00141	CcSEcCtD
Benzonatate—Rash—Nilotinib—hematologic cancer	0.0013	0.00141	CcSEcCtD
Benzonatate—Hypersensitivity—Hydroxyurea—hematologic cancer	0.0013	0.0014	CcSEcCtD
Benzonatate—Rash—Imatinib—hematologic cancer	0.00129	0.0014	CcSEcCtD
Benzonatate—Headache—Nilotinib—hematologic cancer	0.00129	0.0014	CcSEcCtD
Benzonatate—Headache—Imatinib—hematologic cancer	0.00128	0.00139	CcSEcCtD
Benzonatate—Dizziness—Vinblastine—hematologic cancer	0.00128	0.00138	CcSEcCtD
Benzonatate—Convulsion—Cisplatin—hematologic cancer	0.00128	0.00138	CcSEcCtD
Benzonatate—Rash—Cladribine—hematologic cancer	0.00127	0.00137	CcSEcCtD
Benzonatate—Constipation—Thalidomide—hematologic cancer	0.00127	0.00137	CcSEcCtD
Benzonatate—Pruritus—Lenalidomide—hematologic cancer	0.00126	0.00137	CcSEcCtD
Benzonatate—Feeling abnormal—Thiotepa—hematologic cancer	0.00126	0.00137	CcSEcCtD
Benzonatate—Headache—Cladribine—hematologic cancer	0.00126	0.00136	CcSEcCtD
Benzonatate—Nausea—Chlorambucil—hematologic cancer	0.00125	0.00135	CcSEcCtD
Benzonatate—SCN5A—L1CAM interactions—NCAM1—hematologic cancer	0.00123	0.0163	CbGpPWpGaD
Benzonatate—Nausea—Nilotinib—hematologic cancer	0.00122	0.00132	CcSEcCtD
Benzonatate—Feeling abnormal—Thalidomide—hematologic cancer	0.00122	0.00132	CcSEcCtD
Benzonatate—Constipation—Carmustine—hematologic cancer	0.00122	0.00132	CcSEcCtD
Benzonatate—Nausea—Imatinib—hematologic cancer	0.00122	0.00132	CcSEcCtD
Benzonatate—Hypersensitivity—Bortezomib—hematologic cancer	0.00121	0.00131	CcSEcCtD
Benzonatate—Headache—Vinblastine—hematologic cancer	0.00121	0.00131	CcSEcCtD
Benzonatate—Constipation—Alitretinoin—hematologic cancer	0.00121	0.0013	CcSEcCtD
Benzonatate—Hypersensitivity—Bleomycin—hematologic cancer	0.0012	0.0013	CcSEcCtD
Benzonatate—Nausea—Cladribine—hematologic cancer	0.0012	0.00129	CcSEcCtD
Benzonatate—Constipation—Ifosfamide—hematologic cancer	0.00119	0.00129	CcSEcCtD
Benzonatate—Hypersensitivity—Vinorelbine—hematologic cancer	0.00118	0.00128	CcSEcCtD
Benzonatate—Dizziness—Lenalidomide—hematologic cancer	0.00118	0.00128	CcSEcCtD
Benzonatate—Feeling abnormal—Carmustine—hematologic cancer	0.00117	0.00127	CcSEcCtD
Benzonatate—Convulsion—Etoposide—hematologic cancer	0.00117	0.00126	CcSEcCtD
Benzonatate—Dizziness—Hydroxyurea—hematologic cancer	0.00117	0.00126	CcSEcCtD
Benzonatate—Pruritus—Bortezomib—hematologic cancer	0.00116	0.00126	CcSEcCtD
Benzonatate—Feeling abnormal—Alitretinoin—hematologic cancer	0.00116	0.00126	CcSEcCtD
Benzonatate—Constipation—Vincristine—hematologic cancer	0.00116	0.00126	CcSEcCtD
Benzonatate—Rash—Melphalan—hematologic cancer	0.00116	0.00125	CcSEcCtD
Benzonatate—Pruritus—Bleomycin—hematologic cancer	0.00115	0.00125	CcSEcCtD
Benzonatate—Convulsion—Prednisolone—hematologic cancer	0.00115	0.00125	CcSEcCtD
Benzonatate—Feeling abnormal—Ifosfamide—hematologic cancer	0.00115	0.00124	CcSEcCtD
Benzonatate—Nausea—Vinblastine—hematologic cancer	0.00115	0.00124	CcSEcCtD
Benzonatate—SCN5A—Cardiac Progenitor Differentiation—PDGFRA—hematologic cancer	0.00115	0.0152	CbGpPWpGaD
Benzonatate—Pruritus—Vinorelbine—hematologic cancer	0.00114	0.00123	CcSEcCtD
Benzonatate—Constipation—Irinotecan—hematologic cancer	0.00113	0.00122	CcSEcCtD
Benzonatate—Constipation—Mitoxantrone—hematologic cancer	0.00113	0.00122	CcSEcCtD
Benzonatate—Hypersensitivity—Thiotepa—hematologic cancer	0.00113	0.00122	CcSEcCtD
Benzonatate—Rash—Lenalidomide—hematologic cancer	0.00113	0.00122	CcSEcCtD
Benzonatate—Headache—Lenalidomide—hematologic cancer	0.00112	0.00121	CcSEcCtD
Benzonatate—Abdominal discomfort—Methotrexate—hematologic cancer	0.00111	0.0012	CcSEcCtD
Benzonatate—Rash—Hydroxyurea—hematologic cancer	0.00111	0.0012	CcSEcCtD
Benzonatate—Confusional state—Etoposide—hematologic cancer	0.00111	0.0012	CcSEcCtD
Benzonatate—Headache—Hydroxyurea—hematologic cancer	0.0011	0.00119	CcSEcCtD
Benzonatate—Constipation—Gemcitabine—hematologic cancer	0.0011	0.00119	CcSEcCtD
Benzonatate—Hypersensitivity—Thalidomide—hematologic cancer	0.00109	0.00118	CcSEcCtD
Benzonatate—Nausea—Melphalan—hematologic cancer	0.00109	0.00118	CcSEcCtD
Benzonatate—Feeling abnormal—Irinotecan—hematologic cancer	0.00109	0.00118	CcSEcCtD
Benzonatate—Feeling abnormal—Mitoxantrone—hematologic cancer	0.00109	0.00118	CcSEcCtD
Benzonatate—Dizziness—Bortezomib—hematologic cancer	0.00109	0.00118	CcSEcCtD
Benzonatate—Pruritus—Thiotepa—hematologic cancer	0.00108	0.00117	CcSEcCtD
Benzonatate—Shock—Prednisolone—hematologic cancer	0.00107	0.00116	CcSEcCtD
Benzonatate—Feeling abnormal—Gemcitabine—hematologic cancer	0.00106	0.00115	CcSEcCtD
Benzonatate—Dizziness—Vinorelbine—hematologic cancer	0.00106	0.00115	CcSEcCtD
Benzonatate—Nausea—Lenalidomide—hematologic cancer	0.00106	0.00115	CcSEcCtD
Benzonatate—Convulsion—Triamcinolone—hematologic cancer	0.00106	0.00115	CcSEcCtD
Benzonatate—Hypersensitivity—Carmustine—hematologic cancer	0.00105	0.00113	CcSEcCtD
Benzonatate—Pruritus—Thalidomide—hematologic cancer	0.00105	0.00113	CcSEcCtD
Benzonatate—Nausea—Hydroxyurea—hematologic cancer	0.00105	0.00113	CcSEcCtD
Benzonatate—Hypersensitivity—Alitretinoin—hematologic cancer	0.00104	0.00112	CcSEcCtD
Benzonatate—SCN5A—Axon guidance—CHL1—hematologic cancer	0.00104	0.0138	CbGpPWpGaD
Benzonatate—Rash—Bortezomib—hematologic cancer	0.00104	0.00112	CcSEcCtD
Benzonatate—Headache—Bortezomib—hematologic cancer	0.00103	0.00111	CcSEcCtD
Benzonatate—Rash—Bleomycin—hematologic cancer	0.00103	0.00111	CcSEcCtD
Benzonatate—Hypersensitivity—Ifosfamide—hematologic cancer	0.00103	0.00111	CcSEcCtD
Benzonatate—SCN5A—SIDS Susceptibility Pathways—RUNX3—hematologic cancer	0.00102	0.0136	CbGpPWpGaD
Benzonatate—Dizziness—Thiotepa—hematologic cancer	0.00101	0.0011	CcSEcCtD
Benzonatate—Rash—Vinorelbine—hematologic cancer	0.00101	0.00109	CcSEcCtD
Benzonatate—Headache—Vinorelbine—hematologic cancer	0.00101	0.00109	CcSEcCtD
Benzonatate—Hypersensitivity—Vincristine—hematologic cancer	0.001	0.00108	CcSEcCtD
Benzonatate—Pruritus—Alitretinoin—hematologic cancer	0.000998	0.00108	CcSEcCtD
Benzonatate—Feeling abnormal—Cisplatin—hematologic cancer	0.000991	0.00107	CcSEcCtD
Benzonatate—SCN5A—SIDS Susceptibility Pathways—HDAC9—hematologic cancer	0.000989	0.0132	CbGpPWpGaD
Benzonatate—Pruritus—Ifosfamide—hematologic cancer	0.000987	0.00107	CcSEcCtD
Benzonatate—Shock—Triamcinolone—hematologic cancer	0.000983	0.00106	CcSEcCtD
Benzonatate—Dizziness—Thalidomide—hematologic cancer	0.000981	0.00106	CcSEcCtD
Benzonatate—SCN5A—SIDS Susceptibility Pathways—FOXM1—hematologic cancer	0.000979	0.013	CbGpPWpGaD
Benzonatate—SCN5A—Developmental Biology—ABL2—hematologic cancer	0.000978	0.013	CbGpPWpGaD
Benzonatate—Nausea—Bortezomib—hematologic cancer	0.000977	0.00106	CcSEcCtD
Benzonatate—Hypersensitivity—Irinotecan—hematologic cancer	0.000976	0.00106	CcSEcCtD
Benzonatate—Hypersensitivity—Mitoxantrone—hematologic cancer	0.000976	0.00106	CcSEcCtD
Benzonatate—Nausea—Bleomycin—hematologic cancer	0.000969	0.00105	CcSEcCtD
Benzonatate—Rash—Thiotepa—hematologic cancer	0.000967	0.00105	CcSEcCtD
Benzonatate—Convulsion—Dexamethasone—hematologic cancer	0.000962	0.00104	CcSEcCtD
Benzonatate—Convulsion—Betamethasone—hematologic cancer	0.000962	0.00104	CcSEcCtD
Benzonatate—Headache—Thiotepa—hematologic cancer	0.000961	0.00104	CcSEcCtD
Benzonatate—SCN5A—Cardiac Progenitor Differentiation—MAPK14—hematologic cancer	0.000958	0.0127	CbGpPWpGaD
Benzonatate—Nausea—Vinorelbine—hematologic cancer	0.000954	0.00103	CcSEcCtD
Benzonatate—SCN5A—SIDS Susceptibility Pathways—MYB—hematologic cancer	0.000943	0.0125	CbGpPWpGaD
Benzonatate—Dizziness—Carmustine—hematologic cancer	0.000942	0.00102	CcSEcCtD
Benzonatate—Constipation—Etoposide—hematologic cancer	0.000942	0.00102	CcSEcCtD
Benzonatate—Rash—Thalidomide—hematologic cancer	0.000935	0.00101	CcSEcCtD
Benzonatate—Dizziness—Alitretinoin—hematologic cancer	0.000933	0.00101	CcSEcCtD
Benzonatate—Headache—Thalidomide—hematologic cancer	0.000929	0.001	CcSEcCtD
Benzonatate—Dizziness—Ifosfamide—hematologic cancer	0.000922	0.000997	CcSEcCtD
Benzonatate—Pruritus—Gemcitabine—hematologic cancer	0.000913	0.000987	CcSEcCtD
Benzonatate—Nausea—Thiotepa—hematologic cancer	0.000911	0.000985	CcSEcCtD
Benzonatate—SCN5A—Cardiac Progenitor Differentiation—NOTCH1—hematologic cancer	0.000909	0.0121	CbGpPWpGaD
Benzonatate—Feeling abnormal—Etoposide—hematologic cancer	0.000908	0.000982	CcSEcCtD
Benzonatate—Dizziness—Vincristine—hematologic cancer	0.000899	0.000972	CcSEcCtD
Benzonatate—Rash—Carmustine—hematologic cancer	0.000898	0.000971	CcSEcCtD
Benzonatate—Feeling abnormal—Prednisolone—hematologic cancer	0.000895	0.000968	CcSEcCtD
Benzonatate—SCN5A—Developmental Biology—PBX1—hematologic cancer	0.000895	0.0119	CbGpPWpGaD
Benzonatate—Headache—Carmustine—hematologic cancer	0.000892	0.000965	CcSEcCtD
Benzonatate—Shock—Dexamethasone—hematologic cancer	0.000892	0.000964	CcSEcCtD
Benzonatate—Shock—Betamethasone—hematologic cancer	0.000892	0.000964	CcSEcCtD
Benzonatate—Rash—Alitretinoin—hematologic cancer	0.00089	0.000962	CcSEcCtD
Benzonatate—Agitation—Prednisone—hematologic cancer	0.000889	0.000961	CcSEcCtD
Benzonatate—SCN5A—Cardiac Progenitor Differentiation—KIT—hematologic cancer	0.000889	0.0118	CbGpPWpGaD
Benzonatate—Hypersensitivity—Cisplatin—hematologic cancer	0.000886	0.000958	CcSEcCtD
Benzonatate—Headache—Alitretinoin—hematologic cancer	0.000884	0.000956	CcSEcCtD
Benzonatate—Nausea—Thalidomide—hematologic cancer	0.000881	0.000953	CcSEcCtD
Benzonatate—Rash—Ifosfamide—hematologic cancer	0.000879	0.000951	CcSEcCtD
Benzonatate—Dizziness—Irinotecan—hematologic cancer	0.000876	0.000947	CcSEcCtD
Benzonatate—Hypoaesthesia—Epirubicin—hematologic cancer	0.000865	0.000935	CcSEcCtD
Benzonatate—Rash—Vincristine—hematologic cancer	0.000857	0.000927	CcSEcCtD
Benzonatate—Headache—Vincristine—hematologic cancer	0.000852	0.000921	CcSEcCtD
Benzonatate—Nausea—Carmustine—hematologic cancer	0.000846	0.000915	CcSEcCtD
Benzonatate—Nausea—Alitretinoin—hematologic cancer	0.000838	0.000906	CcSEcCtD
Benzonatate—Convulsion—Prednisone—hematologic cancer	0.000838	0.000906	CcSEcCtD
Benzonatate—Rash—Mitoxantrone—hematologic cancer	0.000835	0.000903	CcSEcCtD
Benzonatate—Rash—Irinotecan—hematologic cancer	0.000835	0.000903	CcSEcCtD
Benzonatate—SCN5A—Developmental Biology—EBF1—hematologic cancer	0.000832	0.0111	CbGpPWpGaD
Benzonatate—Headache—Mitoxantrone—hematologic cancer	0.00083	0.000897	CcSEcCtD
Benzonatate—Headache—Irinotecan—hematologic cancer	0.00083	0.000897	CcSEcCtD
Benzonatate—Nausea—Ifosfamide—hematologic cancer	0.000828	0.000896	CcSEcCtD
Benzonatate—Feeling abnormal—Triamcinolone—hematologic cancer	0.000823	0.00089	CcSEcCtD
Benzonatate—Rash—Gemcitabine—hematologic cancer	0.000813	0.00088	CcSEcCtD
Benzonatate—Hypersensitivity—Etoposide—hematologic cancer	0.000812	0.000878	CcSEcCtD
Benzonatate—Headache—Gemcitabine—hematologic cancer	0.000808	0.000874	CcSEcCtD
Benzonatate—SCN5A—Axon guidance—ARHGEF12—hematologic cancer	0.000808	0.0107	CbGpPWpGaD
Benzonatate—Nausea—Vincristine—hematologic cancer	0.000808	0.000873	CcSEcCtD
Benzonatate—SCN5A—SIDS Susceptibility Pathways—IL13—hematologic cancer	0.000807	0.0107	CbGpPWpGaD
Benzonatate—Hypersensitivity—Prednisolone—hematologic cancer	0.0008	0.000866	CcSEcCtD
Benzonatate—Hypoaesthesia—Doxorubicin—hematologic cancer	0.0008	0.000865	CcSEcCtD
Benzonatate—Nausea—Mitoxantrone—hematologic cancer	0.000787	0.000851	CcSEcCtD
Benzonatate—Nausea—Irinotecan—hematologic cancer	0.000787	0.000851	CcSEcCtD
Benzonatate—Pruritus—Etoposide—hematologic cancer	0.000779	0.000843	CcSEcCtD
Benzonatate—Shock—Prednisone—hematologic cancer	0.000777	0.00084	CcSEcCtD
Benzonatate—Nausea—Gemcitabine—hematologic cancer	0.000766	0.000829	CcSEcCtD
Benzonatate—Rash—Cisplatin—hematologic cancer	0.000758	0.00082	CcSEcCtD
Benzonatate—SCN5A—Axon guidance—MYH11—hematologic cancer	0.000751	0.00999	CbGpPWpGaD
Benzonatate—SCN5A—Axon guidance—CNTN2—hematologic cancer	0.000751	0.00999	CbGpPWpGaD
Benzonatate—SCN5A—Cardiac Progenitor Differentiation—FGF2—hematologic cancer	0.000748	0.00995	CbGpPWpGaD
Benzonatate—Feeling abnormal—Dexamethasone—hematologic cancer	0.000747	0.000808	CcSEcCtD
Benzonatate—Feeling abnormal—Betamethasone—hematologic cancer	0.000747	0.000808	CcSEcCtD
Benzonatate—SCN5A—Developmental Biology—CHL1—hematologic cancer	0.000741	0.00986	CbGpPWpGaD
Benzonatate—Hypersensitivity—Triamcinolone—hematologic cancer	0.000736	0.000796	CcSEcCtD
Benzonatate—Dizziness—Etoposide—hematologic cancer	0.000728	0.000788	CcSEcCtD
Benzonatate—SCN5A—SIDS Susceptibility Pathways—GATA3—hematologic cancer	0.000728	0.00968	CbGpPWpGaD
Benzonatate—Dizziness—Prednisolone—hematologic cancer	0.000718	0.000777	CcSEcCtD
Benzonatate—Nausea—Cisplatin—hematologic cancer	0.000714	0.000772	CcSEcCtD
Benzonatate—SCN5A—Developmental Biology—SALL4—hematologic cancer	0.000707	0.00941	CbGpPWpGaD
Benzonatate—SCN5A—Developmental Biology—TCF3—hematologic cancer	0.000707	0.00941	CbGpPWpGaD
Benzonatate—Pruritus—Triamcinolone—hematologic cancer	0.000707	0.000764	CcSEcCtD
Benzonatate—SCN5A—Axon guidance—AGRN—hematologic cancer	0.000706	0.00939	CbGpPWpGaD
Benzonatate—Convulsion—Methotrexate—hematologic cancer	0.0007	0.000757	CcSEcCtD
Benzonatate—Agitation—Epirubicin—hematologic cancer	0.000695	0.000752	CcSEcCtD
Benzonatate—Rash—Etoposide—hematologic cancer	0.000695	0.000751	CcSEcCtD
Benzonatate—Headache—Etoposide—hematologic cancer	0.00069	0.000746	CcSEcCtD
Benzonatate—Rash—Prednisolone—hematologic cancer	0.000685	0.000741	CcSEcCtD
Benzonatate—Headache—Prednisolone—hematologic cancer	0.000681	0.000736	CcSEcCtD
Benzonatate—Constipation—Prednisone—hematologic cancer	0.000675	0.00073	CcSEcCtD
Benzonatate—Confusional state—Methotrexate—hematologic cancer	0.000665	0.000719	CcSEcCtD
Benzonatate—Dizziness—Triamcinolone—hematologic cancer	0.000661	0.000714	CcSEcCtD
Benzonatate—SCN5A—Axon guidance—TIAM1—hematologic cancer	0.000659	0.00876	CbGpPWpGaD
Benzonatate—Convulsion—Epirubicin—hematologic cancer	0.000656	0.000709	CcSEcCtD
Benzonatate—Nausea—Etoposide—hematologic cancer	0.000654	0.000708	CcSEcCtD
Benzonatate—Feeling abnormal—Prednisone—hematologic cancer	0.000651	0.000704	CcSEcCtD
Benzonatate—Nausea—Prednisolone—hematologic cancer	0.000645	0.000698	CcSEcCtD
Benzonatate—Agitation—Doxorubicin—hematologic cancer	0.000643	0.000696	CcSEcCtD
Benzonatate—Pruritus—Dexamethasone—hematologic cancer	0.000641	0.000694	CcSEcCtD
Benzonatate—Pruritus—Betamethasone—hematologic cancer	0.000641	0.000694	CcSEcCtD
Benzonatate—Rash—Triamcinolone—hematologic cancer	0.00063	0.000681	CcSEcCtD
Benzonatate—Headache—Triamcinolone—hematologic cancer	0.000626	0.000677	CcSEcCtD
Benzonatate—Confusional state—Epirubicin—hematologic cancer	0.000623	0.000673	CcSEcCtD
Benzonatate—Shock—Epirubicin—hematologic cancer	0.000608	0.000657	CcSEcCtD
Benzonatate—Convulsion—Doxorubicin—hematologic cancer	0.000607	0.000656	CcSEcCtD
Benzonatate—Dizziness—Dexamethasone—hematologic cancer	0.0006	0.000648	CcSEcCtD
Benzonatate—Dizziness—Betamethasone—hematologic cancer	0.0006	0.000648	CcSEcCtD
Benzonatate—Nausea—Triamcinolone—hematologic cancer	0.000593	0.000642	CcSEcCtD
Benzonatate—Hypersensitivity—Prednisone—hematologic cancer	0.000582	0.000629	CcSEcCtD
Benzonatate—SCN5A—SIDS Susceptibility Pathways—AR—hematologic cancer	0.000577	0.00768	CbGpPWpGaD
Benzonatate—SCN5A—Developmental Biology—ARHGEF12—hematologic cancer	0.000577	0.00767	CbGpPWpGaD
Benzonatate—Confusional state—Doxorubicin—hematologic cancer	0.000576	0.000623	CcSEcCtD
Benzonatate—Rash—Betamethasone—hematologic cancer	0.000572	0.000618	CcSEcCtD
Benzonatate—Rash—Dexamethasone—hematologic cancer	0.000572	0.000618	CcSEcCtD
Benzonatate—SCN5A—Axon guidance—TRIO—hematologic cancer	0.000569	0.00757	CbGpPWpGaD
Benzonatate—Headache—Betamethasone—hematologic cancer	0.000568	0.000614	CcSEcCtD
Benzonatate—Headache—Dexamethasone—hematologic cancer	0.000568	0.000614	CcSEcCtD
Benzonatate—Shock—Doxorubicin—hematologic cancer	0.000562	0.000608	CcSEcCtD
Benzonatate—Pruritus—Prednisone—hematologic cancer	0.000559	0.000604	CcSEcCtD
Benzonatate—Feeling abnormal—Methotrexate—hematologic cancer	0.000544	0.000588	CcSEcCtD
Benzonatate—Nausea—Dexamethasone—hematologic cancer	0.000539	0.000582	CcSEcCtD
Benzonatate—Nausea—Betamethasone—hematologic cancer	0.000539	0.000582	CcSEcCtD
Benzonatate—SCN5A—Developmental Biology—MYH11—hematologic cancer	0.000536	0.00713	CbGpPWpGaD
Benzonatate—SCN5A—Developmental Biology—CNTN2—hematologic cancer	0.000536	0.00713	CbGpPWpGaD
Benzonatate—Constipation—Epirubicin—hematologic cancer	0.000528	0.000571	CcSEcCtD
Benzonatate—Dizziness—Prednisone—hematologic cancer	0.000522	0.000565	CcSEcCtD
Benzonatate—Feeling abnormal—Epirubicin—hematologic cancer	0.000509	0.00055	CcSEcCtD
Benzonatate—SCN5A—SIDS Susceptibility Pathways—HES1—hematologic cancer	0.000507	0.00675	CbGpPWpGaD
Benzonatate—SCN5A—SIDS Susceptibility Pathways—IL10—hematologic cancer	0.000505	0.00671	CbGpPWpGaD
Benzonatate—SCN5A—Developmental Biology—AGRN—hematologic cancer	0.000504	0.0067	CbGpPWpGaD
Benzonatate—SCN5A—Axon guidance—RAC2—hematologic cancer	0.000499	0.00664	CbGpPWpGaD
Benzonatate—Rash—Prednisone—hematologic cancer	0.000498	0.000538	CcSEcCtD
Benzonatate—Headache—Prednisone—hematologic cancer	0.000495	0.000535	CcSEcCtD
Benzonatate—SCN5A—L1CAM interactions—MAP2K1—hematologic cancer	0.000489	0.0065	CbGpPWpGaD
Benzonatate—Constipation—Doxorubicin—hematologic cancer	0.000489	0.000528	CcSEcCtD
Benzonatate—SCN5A—Cardiac Progenitor Differentiation—TGFB1—hematologic cancer	0.000488	0.00649	CbGpPWpGaD
Benzonatate—Hypersensitivity—Methotrexate—hematologic cancer	0.000486	0.000526	CcSEcCtD
Benzonatate—SCN5A—Developmental Biology—CEBPD—hematologic cancer	0.000478	0.00635	CbGpPWpGaD
Benzonatate—SCN5A—Developmental Biology—CEBPA—hematologic cancer	0.000478	0.00635	CbGpPWpGaD
Benzonatate—Feeling abnormal—Doxorubicin—hematologic cancer	0.000471	0.000509	CcSEcCtD
Benzonatate—SCN5A—Developmental Biology—TIAM1—hematologic cancer	0.00047	0.00625	CbGpPWpGaD
Benzonatate—Nausea—Prednisone—hematologic cancer	0.000469	0.000507	CcSEcCtD
Benzonatate—SCN5A—SIDS Susceptibility Pathways—NR3C1—hematologic cancer	0.000467	0.00621	CbGpPWpGaD
Benzonatate—Pruritus—Methotrexate—hematologic cancer	0.000467	0.000505	CcSEcCtD
Benzonatate—SCN5A—Axon guidance—NCAM1—hematologic cancer	0.000464	0.00617	CbGpPWpGaD
Benzonatate—Hypersensitivity—Epirubicin—hematologic cancer	0.000455	0.000492	CcSEcCtD
Benzonatate—Pruritus—Epirubicin—hematologic cancer	0.000437	0.000472	CcSEcCtD
Benzonatate—Dizziness—Methotrexate—hematologic cancer	0.000436	0.000472	CcSEcCtD
Benzonatate—SCN5A—Developmental Biology—NCOR2—hematologic cancer	0.000431	0.00574	CbGpPWpGaD
Benzonatate—Hypersensitivity—Doxorubicin—hematologic cancer	0.000421	0.000455	CcSEcCtD
Benzonatate—Rash—Methotrexate—hematologic cancer	0.000416	0.00045	CcSEcCtD
Benzonatate—Headache—Methotrexate—hematologic cancer	0.000413	0.000447	CcSEcCtD
Benzonatate—Dizziness—Epirubicin—hematologic cancer	0.000408	0.000442	CcSEcCtD
Benzonatate—SCN5A—Developmental Biology—TRIO—hematologic cancer	0.000406	0.0054	CbGpPWpGaD
Benzonatate—Pruritus—Doxorubicin—hematologic cancer	0.000404	0.000437	CcSEcCtD
Benzonatate—SCN5A—Axon guidance—PTPRC—hematologic cancer	0.000395	0.00525	CbGpPWpGaD
Benzonatate—Nausea—Methotrexate—hematologic cancer	0.000392	0.000424	CcSEcCtD
Benzonatate—Rash—Epirubicin—hematologic cancer	0.000389	0.000421	CcSEcCtD
Benzonatate—Headache—Epirubicin—hematologic cancer	0.000387	0.000418	CcSEcCtD
Benzonatate—Dizziness—Doxorubicin—hematologic cancer	0.000378	0.000409	CcSEcCtD
Benzonatate—SCN5A—Developmental Biology—CCND3—hematologic cancer	0.000368	0.0049	CbGpPWpGaD
Benzonatate—Nausea—Epirubicin—hematologic cancer	0.000367	0.000397	CcSEcCtD
Benzonatate—Rash—Doxorubicin—hematologic cancer	0.00036	0.00039	CcSEcCtD
Benzonatate—Headache—Doxorubicin—hematologic cancer	0.000358	0.000387	CcSEcCtD
Benzonatate—SCN5A—SIDS Susceptibility Pathways—CREB1—hematologic cancer	0.000357	0.00474	CbGpPWpGaD
Benzonatate—SCN5A—Developmental Biology—RAC2—hematologic cancer	0.000356	0.00474	CbGpPWpGaD
Benzonatate—SCN5A—SIDS Susceptibility Pathways—IL6R—hematologic cancer	0.000348	0.00463	CbGpPWpGaD
Benzonatate—SCN5A—SIDS Susceptibility Pathways—CREBBP—hematologic cancer	0.000347	0.00462	CbGpPWpGaD
Benzonatate—SCN5A—Axon guidance—HSP90AA1—hematologic cancer	0.000345	0.00459	CbGpPWpGaD
Benzonatate—SCN5A—Developmental Biology—NCOA3—hematologic cancer	0.00034	0.00453	CbGpPWpGaD
Benzonatate—Nausea—Doxorubicin—hematologic cancer	0.000339	0.000367	CcSEcCtD
Benzonatate—SCN5A—L1CAM interactions—SRC—hematologic cancer	0.000339	0.00451	CbGpPWpGaD
Benzonatate—SCN5A—Developmental Biology—NCAM1—hematologic cancer	0.000331	0.0044	CbGpPWpGaD
Benzonatate—SCN5A—Developmental Biology—CTNNA1—hematologic cancer	0.000313	0.00417	CbGpPWpGaD
Benzonatate—SCN5A—L1CAM interactions—MAPK3—hematologic cancer	0.000313	0.00416	CbGpPWpGaD
Benzonatate—SCN5A—Axon guidance—GRB2—hematologic cancer	0.000311	0.00414	CbGpPWpGaD
Benzonatate—SCN5A—Axon guidance—ABL1—hematologic cancer	0.000299	0.00398	CbGpPWpGaD
Benzonatate—SCN5A—Developmental Biology—PTPRC—hematologic cancer	0.000282	0.00375	CbGpPWpGaD
Benzonatate—SCN5A—Axon guidance—JAK1—hematologic cancer	0.000268	0.00357	CbGpPWpGaD
Benzonatate—SCN5A—SIDS Susceptibility Pathways—IL1B—hematologic cancer	0.000265	0.00352	CbGpPWpGaD
Benzonatate—SCN5A—SIDS Susceptibility Pathways—CASP3—hematologic cancer	0.000264	0.00351	CbGpPWpGaD
Benzonatate—SCN5A—SIDS Susceptibility Pathways—JUN—hematologic cancer	0.000256	0.00341	CbGpPWpGaD
Benzonatate—SCN5A—Developmental Biology—HSP90AA1—hematologic cancer	0.000246	0.00327	CbGpPWpGaD
Benzonatate—SCN5A—SIDS Susceptibility Pathways—EP300—hematologic cancer	0.000237	0.00315	CbGpPWpGaD
Benzonatate—SCN5A—SIDS Susceptibility Pathways—VEGFA—hematologic cancer	0.000224	0.00298	CbGpPWpGaD
Benzonatate—SCN5A—Developmental Biology—GRB2—hematologic cancer	0.000222	0.00295	CbGpPWpGaD
Benzonatate—SCN5A—Axon guidance—MET—hematologic cancer	0.000222	0.00295	CbGpPWpGaD
Benzonatate—SCN5A—Developmental Biology—ABL1—hematologic cancer	0.000213	0.00284	CbGpPWpGaD
Benzonatate—SCN5A—Axon guidance—PTPN11—hematologic cancer	0.000205	0.00273	CbGpPWpGaD
Benzonatate—SCN5A—Developmental Biology—HES1—hematologic cancer	0.000202	0.00268	CbGpPWpGaD
Benzonatate—SCN5A—Developmental Biology—NCOR1—hematologic cancer	0.000201	0.00267	CbGpPWpGaD
Benzonatate—SCN5A—Axon guidance—CREB1—hematologic cancer	0.000199	0.00264	CbGpPWpGaD
Benzonatate—SCN5A—Developmental Biology—FOXO1—hematologic cancer	0.000196	0.0026	CbGpPWpGaD
Benzonatate—SCN5A—Axon guidance—IL6R—hematologic cancer	0.000194	0.00258	CbGpPWpGaD
Benzonatate—SCN5A—SIDS Susceptibility Pathways—TNF—hematologic cancer	0.000192	0.00255	CbGpPWpGaD
Benzonatate—SCN5A—Developmental Biology—JAK1—hematologic cancer	0.000191	0.00255	CbGpPWpGaD
Benzonatate—SCN5A—Axon guidance—MAP2K1—hematologic cancer	0.000185	0.00246	CbGpPWpGaD
Benzonatate—SCN5A—Axon guidance—JAK2—hematologic cancer	0.000168	0.00224	CbGpPWpGaD
Benzonatate—SCN5A—Developmental Biology—MAPK14—hematologic cancer	0.000161	0.00214	CbGpPWpGaD
Benzonatate—SCN5A—Developmental Biology—CDK4—hematologic cancer	0.000158	0.00211	CbGpPWpGaD
Benzonatate—SCN5A—Developmental Biology—MET—hematologic cancer	0.000158	0.00211	CbGpPWpGaD
Benzonatate—SCN5A—SIDS Susceptibility Pathways—IL6—hematologic cancer	0.000155	0.00206	CbGpPWpGaD
Benzonatate—SCN5A—Developmental Biology—NOTCH1—hematologic cancer	0.000152	0.00203	CbGpPWpGaD
Benzonatate—SCN5A—Developmental Biology—PTPN11—hematologic cancer	0.000146	0.00195	CbGpPWpGaD
Benzonatate—SCN5A—Developmental Biology—CREB1—hematologic cancer	0.000142	0.00189	CbGpPWpGaD
Benzonatate—SCN5A—Developmental Biology—IL6R—hematologic cancer	0.000138	0.00184	CbGpPWpGaD
Benzonatate—SCN5A—Developmental Biology—CREBBP—hematologic cancer	0.000138	0.00184	CbGpPWpGaD
Benzonatate—SCN5A—Developmental Biology—MAP2K1—hematologic cancer	0.000132	0.00175	CbGpPWpGaD
Benzonatate—SCN5A—Axon guidance—SRC—hematologic cancer	0.000128	0.00171	CbGpPWpGaD
Benzonatate—SCN5A—Developmental Biology—FGF2—hematologic cancer	0.000125	0.00167	CbGpPWpGaD
Benzonatate—SCN5A—Axon guidance—VEGFA—hematologic cancer	0.000125	0.00166	CbGpPWpGaD
Benzonatate—SCN5A—Axon guidance—NRAS—hematologic cancer	0.000123	0.00164	CbGpPWpGaD
Benzonatate—SCN5A—Developmental Biology—JAK2—hematologic cancer	0.00012	0.0016	CbGpPWpGaD
Benzonatate—SCN5A—Axon guidance—MAPK3—hematologic cancer	0.000118	0.00157	CbGpPWpGaD
Benzonatate—SCN5A—Axon guidance—KRAS—hematologic cancer	0.000106	0.00141	CbGpPWpGaD
Benzonatate—SCN5A—Developmental Biology—EP300—hematologic cancer	9.41e-05	0.00125	CbGpPWpGaD
Benzonatate—SCN5A—Developmental Biology—SRC—hematologic cancer	9.15e-05	0.00122	CbGpPWpGaD
Benzonatate—SCN5A—Axon guidance—HRAS—hematologic cancer	9.02e-05	0.0012	CbGpPWpGaD
Benzonatate—SCN5A—Developmental Biology—VEGFA—hematologic cancer	8.91e-05	0.00119	CbGpPWpGaD
Benzonatate—SCN5A—Developmental Biology—STAT3—hematologic cancer	8.82e-05	0.00117	CbGpPWpGaD
Benzonatate—SCN5A—Developmental Biology—NRAS—hematologic cancer	8.8e-05	0.00117	CbGpPWpGaD
Benzonatate—SCN5A—Axon guidance—IL6—hematologic cancer	8.64e-05	0.00115	CbGpPWpGaD
Benzonatate—SCN5A—Developmental Biology—MAPK3—hematologic cancer	8.43e-05	0.00112	CbGpPWpGaD
Benzonatate—SCN5A—Developmental Biology—TGFB1—hematologic cancer	8.18e-05	0.00109	CbGpPWpGaD
Benzonatate—SCN5A—Developmental Biology—TNF—hematologic cancer	7.64e-05	0.00102	CbGpPWpGaD
Benzonatate—SCN5A—Developmental Biology—KRAS—hematologic cancer	7.57e-05	0.00101	CbGpPWpGaD
Benzonatate—SCN5A—Developmental Biology—HRAS—hematologic cancer	6.44e-05	0.000856	CbGpPWpGaD
Benzonatate—SCN5A—Developmental Biology—IL6—hematologic cancer	6.16e-05	0.00082	CbGpPWpGaD
Benzonatate—SCN5A—Developmental Biology—AKT1—hematologic cancer	5.69e-05	0.000756	CbGpPWpGaD
